User profiles for Y. Anzai
Yoshimi AnzaiProfessor of Radiology, University of Utah School of Medicine Verified email at hsc.utah.edu Cited by 11876 |
Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants
A rapidly emerging clinical application of positron emission tomography (PET) is the
detection and staging of cancer with the glucose analogue tracer 2-[fluorine-18]fluoro-2-deoxy-d-…
detection and staging of cancer with the glucose analogue tracer 2-[fluorine-18]fluoro-2-deoxy-d-…
Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature
… approximately 4 y until the final clinical diagnosis and an additional average of 5 y until death
… are similar to longitudinal clinical diagnosis over approximately 4 y (39). Furthermore, the …
… are similar to longitudinal clinical diagnosis over approximately 4 y (39). Furthermore, the …
Imaging evidence and recommendations for traumatic brain injury: conventional neuroimaging techniques
M Wintermark, PC Sanelli, Y Anzai, AJ Tsiouris… - Journal of the American …, 2015 - Elsevier
Imaging plays an essential role in identifying intracranial injury in patients with traumatic brain
injury (TBI). The goals of imaging include (1) detecting injuries that may require immediate …
injury (TBI). The goals of imaging include (1) detecting injuries that may require immediate …
Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology
…, S Spencer, D Adelstein, D Adkins, Y Anzai… - Journal of the National …, 2020 - jnccn.org
Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning …
disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning …
Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence.
Y Anzai, H Kim, JY Park… - … of systematic and …, 2000 - microbiologyresearch.org
… Amplification of the 16S rRNA coding region of the DNA and sequencing of the 16S
rDNA were performed as described by Anzai et al. (1997). The 16S rDNA sequences were …
rDNA were performed as described by Anzai et al. (1997). The 16S rDNA sequences were …
The theory of learning by doing.
Y Anzai, HA Simon - Psychological review, 1979 - psycnet.apa.org
… system and the representation it employs are discussed from an artificial intelligence
viewpoint in Anzai (1978a), and computational results are described in detail in Anzai (1978b). …
viewpoint in Anzai (1978a), and computational results are described in detail in Anzai (1978b). …
Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer
LA Dawson, Y Anzai, L Marsh, MK Martel… - International Journal of …, 2000 - Elsevier
Purpose: To analyze the patterns of local-regional recurrence in patients with head and
neck cancer treated with parotid-sparing conformal and segmental intensity-modulated …
neck cancer treated with parotid-sparing conformal and segmental intensity-modulated …
The Phylogeny of the Genera Chryseomonas, Flavimonas, and Pseudomonas Supports Synonymy of These Three Genera
Y Anzai, Y Kudo, H Oyaizu - International Journal of …, 1997 - microbiologyresearch.org
The 16S rRNA sequences of Chryseomonas luteola, the type species of the genus
Chryseomonas, and Flavimonas oryzihabitans, the type species of the genus Flavimonas, were …
Chryseomonas, and Flavimonas oryzihabitans, the type species of the genus Flavimonas, were …
Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck
DM Don, TC Calcaterra, Y Anzai, RB Lufkin… - The …, 1995 - Wiley Online Library
Although computed tomography and magnetic resonance imaging have contributed to the
ability to identify metastatic disease in head and neck Cancer, inadequacies in evaluating …
ability to identify metastatic disease in head and neck Cancer, inadequacies in evaluating …
Evaluation of neck and body metastases to nodes with ferumoxtran 10–enhanced MR imaging: phase III safety and efficacy study
Y Anzai, CW Piccoli, EK Outwater, W Stanford… - Radiology, 2003 - pubs.rsna.org
PURPOSE: To determine the safety and efficacy of ferumoxtran 10–enhanced magnetic
resonance (MR) imaging for diagnosis of metastases to lymph nodes and the clinical usefulness …
resonance (MR) imaging for diagnosis of metastases to lymph nodes and the clinical usefulness …